Weigang Shu
- Topics
- Inflammatory Bowel Disease (5 papers)IL-33, ST2, and ILC Pathways (4 papers)Immune Response and Inflammation (2 papers)
- Cited by
- ImmunologyGeneticsGastroenterology
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Weigang Shu
10 papers receiving 365 citations
Peers
Comparison fields: 5 of 74
- Molecular Biology 147
- Immunology 142
- Genetics 103
- Oncology 63
- Epidemiology 59
Countries citing papers authored by Weigang Shu
This map shows the geographic impact of Weigang Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weigang Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weigang Shu more than expected).
Fields of papers citing papers by Weigang Shu
This network shows the impact of papers produced by Weigang Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weigang Shu. The network helps show where Weigang Shu may publish in the future.
Co-authorship network of co-authors of Weigang Shu
This figure shows the co-authorship network connecting the top 25 collaborators of Weigang Shu. A scholar is included among the top collaborators of Weigang Shu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weigang Shu. Weigang Shu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 15 | |
| 4 | 25 | |
| 5 | 19 | |
| 6 | 56 | |
| 7 | 53 | |
| 8 | 90 | |
| 9 | 43 | |
| 10 | 62 |
About Weigang Shu
Weigang Shu is a scholar working on Immunology, Physiology and Hematology, having authored 10 papers that have together received 366 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (5 papers), IL-33, ST2, and ILC Pathways (4 papers) and Immune Response and Inflammation (2 papers). The work is most often cited by research in Immunology (142 citations), Genetics (103 citations) and Gastroenterology (19 citations). Weigang Shu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Zhanju Liu, Wei Wu, Zhi Pang, Guangxi Zhou, Mingming Sun, Leilei Fang, Yingzi Cong, Jian Lin, Cui Zhang and Huili Wu. Their work appears in journals such as Gastroenterology, Carcinogenesis and Inflammatory Bowel Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.